NPI Details
DR. Paul David Weinstein, MD is an internal medicine in Scarsdale, NY with 42 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Paul David Weinstein, MD NPI is 1316027030. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Graduation Year:1984
The provider's business location address is:
1075 CENTRAL PARK AVENUE
SCARSDALE, NY
ZIP 10583-242
Phone: (914) 725-6688
Fax: (914) 725-6860
The NPI 1316027030 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
- Blood test, comprehensive group of blood chemicals (HCPCS:80053)
- Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
- Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
- Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
- Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS:94060)
- Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
- Test to determine lung volumes using gas dilution or washout (HCPCS:94727)
- Test to examine how well the lungs exchange gases (HCPCS:94729)
- Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
- New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
- Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme (HCPCS:J7620)
- Test for exercise-induced lung stress (HCPCS:94618)
- New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
- Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
- Hemoglobin a1c level (HCPCS:83036)
- Vitamin d-3 level (HCPCS:82306)
- Administration of influenza virus vaccine (HCPCS:G0008)
- Influenza vaccine split virus, preservative free (HCPCS:90662)
- Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
- Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
- Rheumatoid factor level (HCPCS:86431)
- Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
- Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
- Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
- Stool analysis for blood, by fecal hemoglobin determination by immunoassay (HCPCS:82274)
- Psa (prostate specific antigen) measurement, total (HCPCS:84153)
- Thyroxine (thyroid chemical), free (HCPCS:84439)
- Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
- Psa (prostate specific antigen) measurement, free (HCPCS:84154)
- Magnesium level (HCPCS:83735)
- Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
The enumeration date for this NPI number is 10/17/2006 and was last updated on 11/18/2013.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207RC0200X | Internal Medicine | Critical Care Medicine | 164817 | NEW YORK | No |
| 2 | 207RP1001X | Internal Medicine | Pulmonary Disease | 164817 | NEW YORK | No |
| 3 | 207R00000X | Internal Medicine | | 164817 | NEW YORK | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | P010164817 | OTHER | | CORE SOURCE |
| 2 | 290003844 | OTHER | NEW YORK | RR MEDICARE |
| 3 | 01808584 | MEDICAID | NEW YORK | |
| 4 | 133598462 | OTHER | | UNITED HEALTH CARE |
| 5 | 133598462 | OTHER | | CONSUMER HEALTH NETWORK |
| 6 | 1C8612 | OTHER | | HEALTHNET |
| 7 | 561130 | OTHER | | UNITED HEALTH CARE |
| 8 | E69884 | MEDICARE UPIN | | |
| 9 | 70F791 | MEDICARE PIN | NEW YORK | |
| 10 | WP371 | OTHER | | OXFORD |
| 11 | 70F791 | OTHER | | EMPIRE BCBS OF NY |
| 12 | 133598462 | OTHER | | CIGNA |